CIK 0001437402 · Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $486,197
- in 8 filings
Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- RAAB MICHAEL −$226K President & CEO sold 3% of stake
- Bishop John E −$76K See Remarks sold 6% of stake
- Brady James Parker −$58K Chief Human Resources Officer sold 6% of stake
- Williams Laura A −$41K Chief Patient Officer sold 3% of stake
- Foster Eric Duane −$33K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-21 | Hohenleitner Susan Chief Financial Officer | Sale | −1,558 | $3.86 | $6K | 227,520 |
| 2026-08-21 | Brady James Parker Chief Human Resources Officer | Sale | −1,976 | $3.86 | $8K | 259,090 |
| 2026-08-21 | Brady James Parker Chief Human Resources Officer | Sale | −13,160 | $3.86 | $51K | 245,930 |
| 2026-08-21 | Reilly Joseph James See Remarks | Sale | −2,872 | $3.86 | $11K | 146,964 |
| 2026-08-21 | Reilly Joseph James See Remarks | Sale | −1,110 | $3.86 | $4K | 145,854 |
| 2026-08-21 | Foster Eric Duane Chief Commercial Officer | Sale | −2,598 | $3.86 | $10K | 415,374 |
| 2026-08-21 | Foster Eric Duane Chief Commercial Officer | Sale | −3,389 | $3.86 | $13K | 411,985 |
| 2026-08-21 | Foster Eric Duane Chief Commercial Officer | Sale | −2,575 | $3.86 | $10K | 409,410 |
| 2026-08-21 | Kelliher Mike Chief Business Officer | Sale | −3,104 | $3.86 | $12K | 354,314 |
| 2026-08-21 | Kelliher Mike Chief Business Officer | Sale | −2,652 | $3.86 | $10K | 351,662 |
| 2026-08-21 | Kelliher Mike Chief Business Officer | Sale | −2,002 | $3.86 | $8K | 349,660 |
| 2026-08-21 | Williams Laura A Chief Patient Officer | Sale | −3,486 | $3.86 | $13K | 374,709 |
| 2026-08-21 | Williams Laura A Chief Patient Officer | Sale | −3,089 | $3.86 | $12K | 371,620 |
| 2026-08-21 | Williams Laura A Chief Patient Officer | Sale | −2,430 | $3.86 | $9K | 369,190 |
| 2026-08-21 | Williams Laura A Chief Patient Officer | Sale | −1,734 | $3.86 | $7K | 367,456 |
| 2026-08-21 | RAAB MICHAEL President & CEO | Sale | −15,009 | $3.86 | $58K | 1,663,357 |
| 2026-08-21 | RAAB MICHAEL President & CEO | Sale | −15,976 | $3.86 | $62K | 1,647,381 |
| 2026-08-21 | RAAB MICHAEL President & CEO | Sale | −8,411 | $3.86 | $32K | 1,638,970 |
| 2026-08-21 | RAAB MICHAEL President & CEO | Sale | −19,178 | $3.86 | $74K | 1,619,792 |
| 2026-08-21 | Bishop John E See Remarks | Sale | −17,281 | $3.86 | $67K | 319,564 |
Page 1 of 11 · 206 trades